Inhibition of AR-Mediated Transcription by Binding of Oct1 to a Motif Enrichedin AR-Occupied Regions

被引:8
作者
Jariwala, Unnati [2 ,3 ]
Cogan, Jon P. [2 ,3 ]
Jia, Li [1 ,4 ]
Frenkel, Baruch [2 ,3 ,5 ]
Coetzee, Gerhard A. [1 ,4 ,6 ]
机构
[1] Univ So Calif, Keck Sch Med, Norris Canc Ctr, Los Angeles, CA 90033 USA
[2] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA
[3] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA
[4] Univ So Calif, Keck Sch Med, Dept Urol, Los Angeles, CA 90033 USA
[5] Univ So Calif, Keck Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90033 USA
[6] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA
关键词
prostate cancer; androgen receptor; transcription; repression; target genes; Oct1; ANDROGEN-RECEPTOR; TISSUE TRANSGLUTAMINASE; PROSTATE-CANCER; RESISTANT; EXPRESSION; SYNERGISM; REVEALS; BIOLOGY;
D O I
10.1002/pros.20893
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. The androgen receptor (AR) plays roles in prostate development and cancer (PCa). In response to androgens, the AR binds to androgen-response elements (AREs) to modulate gene transcription. The responses of such genes are dependent on the cellular milieu and on sequences around the AREs, which attract other transcription factors. Previously, bioinformatic analysis of 62 AR-occupied regions (ARORs) in PCa cells revealed enrichment for both AREs and a TTGGCAAATA-like motif. We undertook the present study to investigate the significance of the TTGGCAAATA-like motif. METHODS. Prostate cancer cell lines, LNCaP and C4-2B, were analyzed by transient transfections of wild-type and mutant reporter constructs, electro-mobility shift assays (EMSAs), and RT-qPCR analysis of endogenous genes. RESULTS. In two of six tested ARORs, point mutations in the TTGGCAAATA-like motif resulted in inhibition of DHT-mediated enhancer activity. EMSA revealed that Oct1 bound the motif, and that the mutations that abolished DHT responsiveness in the transfection assays augmented Oct1 binding. These results suggest a role for Oct1 as a context-dependent negative coregulator of AR. Consistent with this, siRNA kmockdown of Oct1 increased the DHT-mediated enhancer activity of transfected reporters as well as an endogenous AR target gene, transglutaminase 2. CONCLUSIONS. Oct1 negatively regulates DHT-mediated enhancer activity in a subset of ARORs. The enrichment of ARORs for the Oct-binding, TTGGCAAATA-like motif may reflect a mechanism that utilizes Oct1 to keep AR activity in check at some ARORs, while augmenting AR activity in other ARORs. Therefore, Oct1 may have regulatory functions in prostate development and cancer progression. Prostate 69: 392-400, 2009. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:392 / 400
页数:9
相关论文
共 35 条
  • [1] Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb.
    Boehm, JE
    Singh, U
    Combs, C
    Antonyak, MA
    Cerione, RA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (23) : 20127 - 20130
  • [2] Cell- and gene-specific regulation of primary target genes by the androgen receptor
    Bolton, Eric C.
    So, Alex Y.
    Chaivorapol, Christina
    Haqq, Christopher M.
    Li, Hao
    Yamamoto, Keith R.
    [J]. GENES & DEVELOPMENT, 2007, 21 (16) : 2005 - 2017
  • [3] Contribution of the androgen receptor to prostate cancer predisposition and progression
    Buchanan, G
    Irvine, RA
    Coetzee, GA
    Tilley, WD
    [J]. CANCER AND METASTASIS REVIEWS, 2001, 20 (3-4) : 207 - 223
  • [4] Genome-wide analysis of estrogen receptor binding sites
    Carroll, Jason S.
    Meyer, Clifford A.
    Song, Jun
    Li, Wei
    Geistlinger, Timothy R.
    Eeckhoute, Jerome
    Brodsky, Alexander S.
    Keeton, Erika Krasnickas
    Fertuck, Kirsten C.
    Hall, Giles F.
    Wang, Qianben
    Bekiranov, Stefan
    Sementchenko, Victor
    Fox, Edward A.
    Silver, Pamela A.
    Gingeras, Thomas R.
    Liu, X. Shirley
    Brown, Myles
    [J]. NATURE GENETICS, 2006, 38 (11) : 1289 - 1297
  • [5] Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1
    Carroll, JS
    Liu, XS
    Brodsky, AS
    Li, W
    Meyer, CA
    Szary, AJ
    Eeckhoute, J
    Shao, WL
    Hestermann, EV
    Geistlinger, TR
    Fox, EA
    Silver, PA
    Brown, M
    [J]. CELL, 2005, 122 (01) : 33 - 43
  • [6] Cerenkov line-like radiation and origin of iron Kα line in GRBs
    Chen, L
    Liu, DB
    Xu, YD
    You, JH
    [J]. NEW ASTRONOMY, 2004, 10 (01) : 39 - 52
  • [7] Mechanisms of androgen-refractory prostate cancer.
    Debes, JD
    Tindall, DJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (15) : 1488 - 1490
  • [8] The development of androgen-independent prostate cancer
    Feldman, BJ
    Feldman, D
    [J]. NATURE REVIEWS CANCER, 2001, 1 (01) : 34 - 45
  • [9] Molecular biology of the androgen receptor
    Gelmann, EP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (13) : 3001 - 3015
  • [10] Oct-1 preferentially interacts with androgen receptor in a DNA-dependent manner that facilitates recruitment of SRC-1
    Gonzalez, MI
    Robins, DM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (09) : 6420 - 6428